PGEN

Precigen Inc

• PUBT·3d ago

  Precigen CEO Helen Sabzevari disposes of 346,836 common shares worth $2,042,858.04

• Simply Wall St·3d ago

  Does Precigen’s (PGEN) Russell Value Index Exit Signal a Shifting Investor Base or Story?

• Seeking Alpha·06/26 19:37

  Precigen: Entering The Oncology 'Sweet Spot'

• TipRanks·06/24 20:31

  Precigen Shareholders Expand Incentive Plan, Reaffirm Governance

• PUBT·06/24 20:08

  Precigen shareholders approve 7 million-share increase to 2023 incentive plan at annual meeting

• Simply Wall St·06/24 11:06

  Clearfield And 2 Insider Picks For Strong Growth

• Simply Wall St·06/23 13:35

  Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS Therapy - What's Changed

• Simply Wall St·06/21 02:22

  Precigen (PGEN) Stock Could Be 79% Undervalued After FDA Exclusivity Win

• Simply Wall St·06/15 19:12

  Why Precigen (PGEN) Is Up 24.6% After FDA Orphan Exclusivity Win For PAPZIMEOS

• PUBT·06/15 10:40

  Precigen reports PAPZIMEOS trial data show 83% complete responses sustained at least 36 months in RRP

• Simply Wall St·06/12 06:25

  Precigen (PGEN) Stock After PAPZIMEOS Approval And Exclusivity What The Valuation Signals Suggest

• NASDAQ·06/12 03:54

  Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...

• PR Newswire·06/11 12:00

  Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices

• Simply Wall St·06/06 19:21

  Can PAPZIMEOS Durability Data Redefine Precigen’s (PGEN) Long-Term Revenue and Immunotherapy Narrative?

• Simply Wall St·06/05 03:28

  Assessing Precigen (PGEN) Valuation After PAPZIMEOS Approval And Positive Long Term RRP Data